Weekly Spotlight - 27.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

Latest News

Huntington's Families Share Experiences with FDA to Advance Treatments

The Huntington's Disease Society of America facilitated a meeting between Huntington's disease families and the FDA to share personal experiences and advocate for better treatments. This event highlighted the challenges faced by those affected and aimed to influence future drug development, fostering hope and community support. 

Sage Therapeutics' Huntington's Drug Trial Ends Without Success

Sage Therapeutics' experimental drug, dalzanemdor, aimed at treating cognitive impairment in Huntington's disease, did not meet its primary or secondary goals in a mid-stage trial. Despite this setback, the focus remains on supporting patients and exploring other avenues for treatment, fostering hope for future advancements. 

Astrocytes: Key Players in Huntington's Disease Progression and Therapy

Astrocytes, star-shaped brain cells, may influence Huntington's disease progression by affecting nerve cell health. A Columbia University study highlights their role, suggesting new therapeutic targets. Understanding astrocyte interactions could lead to better treatments, emphasising the importance of community support and organ donation for research advancements. 

Huntington's Disease: New Hope in Emerging Treatments

Recent advancements in Huntington's disease treatments offer hope. Despite past setbacks, promising therapies like uniQure's AMT-130 and Wave's WVE-003 show potential. These developments, alongside ongoing trials, suggest a brighter future for patients. The community remains optimistic, driven by new genetic insights and continued research efforts.